Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02356900 · ClinicalTrials.gov registry record · Phase 2
Hyperbaric VO2max Study
A Phase 2 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT02356900 is a Phase 2 study that was terminated before completion, run by Duke University. The registered enrollment target is 25 participants.
The verdict
NCT02356900, a Phase 2 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study seeks to examine the effectiveness of training while in a hyperoxic-hyperbaric environment for exercise performance at altitude. Subjects will complete a short, high-intensity interval training (HIT) program inside the hyperbaric chamber.Before and after this training phase, all subjects will be tested for maximum aerobic capacity at a simulated high altitude of 15,000ft in a hypobaric chamber, as well as for molecular markers of mitochondrial oxidative capacity in a skeletal muscle biopsy. A group of individuals of similar characteristics completing this training program in a normoxic-normobaric environment will serve as a control.
Interventions
- DRUG Oxygen
- PROCEDURE Hyperoxic hyperbaric interval exercise training
- PROCEDURE Normoxic, normobaric, interval exercise training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02356900
The ClinicalTrials.gov registry entry for NCT02356900 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Oxygen is the first listed.
NCT02356900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02356900 about?
NCT02356900 is a clinical study titled "Hyperbaric VO2max Study". This study seeks to examine the effectiveness of training while in a hyperoxic-hyperbaric environment for exercise performance at altitude. Subjects will complete a short, high-intensity interval training (HIT) program inside the hyperbaric chamber.Before and after this training phase, all subjects ...
What is the current status of trial NCT02356900?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2015-02. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02356900?
The interventions under investigation include: Oxygen (DRUG), Hyperoxic hyperbaric interval exercise training (PROCEDURE), Normoxic, normobaric, interval exercise training (PROCEDURE).
Who is sponsoring clinical trial NCT02356900?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.